Literature DB >> 33679609

The Role of β Cell Stress and Neo-Epitopes in the Immunopathology of Type 1 Diabetes.

Jon D Piganelli1, Mark J Mamula2, Eddie A James3.   

Abstract

Due to their secretory function, β cells are predisposed to higher levels of endoplasmic reticulum (ER) stress and greater sensitivity to inflammation than other cell types. These stresses elicit changes in β cells that alter their function and immunogenicity, including defective ribosomal initiation, post-translational modifications (PTMs) of endogenous β cell proteins, and alternative splicing. Multiple published reports confirm the presence of not only CD8+ T cells, but also autoreactive CD4+ T cells within pancreatic islets. Although the specificities of T cells that infiltrate human islets are incompletely characterized, they have been confirmed to include neo-epitopes that are formed through stress-related enzymatic modifications of β cell proteins. This article summarizes emerging knowledge about stress-induced changes in β cells and data supporting a role for neo-antigen formation and cross-talk between immune cells and β cells that provokes autoimmune attack - leading to a breakdown in tissue-specific tolerance in subjects who develop type 1 diabetes.
Copyright © 2021 Piganelli, Mamula and James.

Entities:  

Keywords:  Beta Cell (β cell); ER stress; immune cells; neo-antigen; post-translational modification; type 1 diabetes (T1D)

Mesh:

Substances:

Year:  2021        PMID: 33679609      PMCID: PMC7930070          DOI: 10.3389/fendo.2020.624590

Source DB:  PubMed          Journal:  Front Endocrinol (Lausanne)        ISSN: 1664-2392            Impact factor:   5.555


  139 in total

Review 1.  Posttranslational protein modifications: new flavors in the menu of autoantigens.

Authors:  Hester A Doyle; Mark J Mamula
Journal:  Curr Opin Rheumatol       Date:  2002-05       Impact factor: 5.006

2.  Isoaspartyl post-translational modification triggers autoimmune responses to self-proteins.

Authors:  M J Mamula; R J Gee; J I Elliott; A Sette; S Southwood; P J Jones; P R Blier
Journal:  J Biol Chem       Date:  1999-08-06       Impact factor: 5.157

Review 3.  Redox-Sensitive Innate Immune Pathways During Macrophage Activation in Type 1 Diabetes.

Authors:  Ashley R Burg; Hubert M Tse
Journal:  Antioxid Redox Signal       Date:  2017-11-27       Impact factor: 8.401

4.  Inherent ER stress in pancreatic islet β cells causes self-recognition by autoreactive T cells in type 1 diabetes.

Authors:  Meghan L Marré; Jennifer L Profozich; Jorge T Coneybeer; Xuehui Geng; Suzanne Bertera; Michael J Ford; Massimo Trucco; Jon D Piganelli
Journal:  J Autoimmun       Date:  2016-05-09       Impact factor: 7.094

5.  Chromogranin A is an autoantigen in type 1 diabetes.

Authors:  Brian D Stadinski; Thomas Delong; Nichole Reisdorph; Richard Reisdorph; Roger L Powell; Michael Armstrong; Jon D Piganelli; Gene Barbour; Brenda Bradley; Frances Crawford; Philippa Marrack; Sushil K Mahata; John W Kappler; Kathryn Haskins
Journal:  Nat Immunol       Date:  2010-02-07       Impact factor: 25.606

6.  Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice.

Authors:  I L Campbell; T W Kay; L Oxbrow; L C Harrison
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

7.  Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients.

Authors:  Francesco Dotta; Stefano Censini; Astrid G S van Halteren; Lorella Marselli; Matilde Masini; Sabrina Dionisi; Franco Mosca; Ugo Boggi; Andrea Onetti Muda; Stefano Del Prato; John F Elliott; Antonello Covacci; Rino Rappuoli; Bart O Roep; Piero Marchetti
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-14       Impact factor: 11.205

8.  Self-peptides in the initiation of lupus autoimmunity.

Authors:  L K Bockenstedt; R J Gee; M J Mamula
Journal:  J Immunol       Date:  1995-04-01       Impact factor: 5.422

Review 9.  The role for endoplasmic reticulum stress in diabetes mellitus.

Authors:  Décio L Eizirik; Alessandra K Cardozo; Miriam Cnop
Journal:  Endocr Rev       Date:  2007-11-29       Impact factor: 19.871

10.  Environmental Factors Contribute to β Cell Endoplasmic Reticulum Stress and Neo-Antigen Formation in Type 1 Diabetes.

Authors:  Meghan L Marré; Jon D Piganelli
Journal:  Front Endocrinol (Lausanne)       Date:  2017-09-29       Impact factor: 5.555

View more
  6 in total

Review 1.  Enteroviruses and Type 1 Diabetes: Multiple Mechanisms and Factors?

Authors:  Richard E Lloyd; Manasi Tamhankar; Åke Lernmark
Journal:  Annu Rev Med       Date:  2021-11-18       Impact factor: 16.048

Review 2.  Functional Impact of Risk Gene Variants on the Autoimmune Responses in Type 1 Diabetes.

Authors:  Chelsea Gootjes; Jaap Jan Zwaginga; Bart O Roep; Tatjana Nikolic
Journal:  Front Immunol       Date:  2022-05-04       Impact factor: 8.786

3.  Found in Translation: Novel Insights Into Type 1 Diabetes and β-Cell Biology.

Authors:  Holger A Russ; Howard W Davidson
Journal:  Diabetes       Date:  2021-10       Impact factor: 9.337

Review 4.  Extracellular Vesicle Therapy for Type 1 Diabetes.

Authors:  Setareh Soltani; Kamran Mansouri; Mohammad Sajad Emami Aleagha; Narges Moasefi; Niloofar Yavari; Seyed Kazem Shakouri; Sara Notararigo; Ali Shojaeian; Flemming Pociot; Reza Yarani
Journal:  Front Immunol       Date:  2022-04-08       Impact factor: 8.786

Review 5.  β-Cell failure in diabetes: Common susceptibility and mechanisms shared between type 1 and type 2 diabetes.

Authors:  Hiroshi Ikegami; Naru Babaya; Shinsuke Noso
Journal:  J Diabetes Investig       Date:  2021-06-16       Impact factor: 4.232

6.  A Humanized Mouse Strain That Develops Spontaneously Immune-Mediated Diabetes.

Authors:  Sandrine Luce; Sophie Guinoiseau; Alexis Gadault; Franck Letourneur; Patrick Nitschke; Marc Bras; Michel Vidaud; Pierre Charneau; Etienne Larger; Maikel L Colli; Decio L Eizirik; François Lemonnier; Christian Boitard
Journal:  Front Immunol       Date:  2021-10-14       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.